Description
Thirty percent of the global population have too much fat in their liver. The big question is: Are they really sick when most will not end up with liver disease?
This episode discusses:
- How should they be assessed and by whom?
- What does this mean to healthcare systems?
- Are there downsides to systematic screening?
Faculty
- Aleksander Krag (Moderator)
- Alina Allen (Faculty)
- Manal El-Sayed (Faculty)
- Ian Rowe (Faculty
Related episode
- EASL Studio Live from EASL Congress 2023: Steatotic liver disease global consensus to change nomenclature
ℹ️ Please click here to access the podcast version of this EASL Studio episode.
This EASL Studio is supported by an educational grant from NOVO NORDISK A/S.